Arcus Biosciences Stock Forecast

Stock Price Forecast

According to 13 analysts polled by S&P Global, Arcus Biosciences stock has a consensus rating of "Strong Buy" and an average price target of $39.91. The average 1-year stock price forecast is 77.30% higher than the current stock price, while the lowest is $23 (+2.18%) and the highest is $47 (+108.80%).

Price Target: $39.91 (+77.30%)

Analyst Consensus: Strong Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$23	$39.91	$43	$47
Change	+2.18%	+77.30%	+91.03%	+108.80%

Analyst Ratings

The average analyst rating for Arcus Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart

Rating	May '26	Jun '26	Jul '26	Aug '26	Sep '26	Oct '26
Strong Buy	9	10	10	10	11	11
Buy	0	0	0	0	0	0
Hold	3	3	3	3	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	12	13	13	13	13	13

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jason Zemansky Bank of America Securities	Bank of America Securities	Hold Maintains $29	Hold	Maintains	$29	+28.83%	Oct 5, 2026
Charles Zhu LifeSci Capital	LifeSci Capital	Buy Maintains $46	Buy	Maintains	$46	+104.35%	Oct 3, 2026
Robert Driscoll Wedbush	Wedbush	Buy Maintains $43	Buy	Maintains	$43	+91.03%	Sep 30, 2026
Emily Bodnar H.C. Wainwright	H.C. Wainwright	Buy Maintains $45	Buy	Maintains	$45	+99.91%	Sep 25, 2026
Tara Bancroft TD Cowen	TD Cowen	Buy Initiates n/a	Buy	Initiates	n/a	n/a	Sep 16, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

78.61M

from 247.00M

-68.17%

from 247.00M

Revenue Next Year

50.68M

from 78.61M

-35.53%

from 78.61M

EPS This Year

-3.48

from -3.29

EPS Next Year

-3.27

from -3.48

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	383.00M	112.00M	117.00M	258.00M	247.00M	78.61M
Revenue Growth	391.03%	-70.76%	4.46%	120.51%	-4.26%	-68.17%
Operating Income	54.00M	-280.00M	-340.00M	-310.00M	-386.00M	-470.17M
Net Income	53.00M	-267.00M	-307.00M	-283.00M	-353.00M	-446.37M
EPS	-	-	-	-	-3.29	-3.48
Free Cash Flow	-	-	-	-	-484.00M	-310.67M
No. Analysts	-	-	-	-	-	11

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	108.0M
Avg	78.6M
Low	58.0M

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	-56.3%
Avg	-68.2%
Low	-76.5%

EPS Forecast

Chart

EPS	2026	2027	2028
High	-2.79
Avg	-3.48
Low	-4.35

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-